Financhill
Buy
58

GH Quote, Financials, Valuation and Earnings

Last price:
$43.88
Seasonality move :
15.41%
Day range:
$41.85 - $44.03
52-week range:
$15.81 - $50.89
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
7.13x
P/B ratio:
32.59x
Volume:
1.5M
Avg. volume:
2.5M
1-year change:
141.83%
Market cap:
$5.3B
Revenue:
$739M
EPS (TTM):
-$3.56

Earnings Data

Next earnings date for GH
May 09
2025
Most recent earnings per share
-$0.90
Missed by $0.40
(Feb 20/2025)
Consensus Estimate
-$0.50
(Feb 20/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

GH Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
05/09/2025 Q1 $190M -- -- -$0.58 --
02/20/2025 Q4 $192.5M $201.8M -$0.90 -$0.50 -$0.40
11/06/2024 Q3 $170.6M $191.5M -$0.88 -$0.60 -$0.28
08/07/2024 Q2 $162.6M $177.2M -$0.84 -$0.61 -$0.23
05/09/2024 Q1 $149.8M $168.5M -$0.94 -$0.73 -$0.21
02/22/2024 Q4 $150.8M $155.1M -$1.58 -$0.75 -$0.83
11/06/2023 Q3 -- -- -$0.73 -$0.80 $0.07
08/03/2023 Q2 -- -- -$0.67 -$0.93 $0.26
05/09/2023 Q1 -- -- -$1.30 -$1.07 -$0.23
02/23/2023 Q4 -- -- -$1.36 -$1.16 -$0.20
11/03/2022 Q3 -- -- -$1.58 -$1.08 -$0.50
08/04/2022 Q2 -- -- -$2.25 -$0.97 -$1.28
05/05/2022 Q1 -- -- -$1.21 -$1.10 -$0.11
02/23/2022 Q4 -- -- -$0.89 -$1.08 $0.19
11/04/2021 Q3 -- -- -$1.06 -$0.87 -$0.19
08/05/2021 Q2 -- -- -$0.96 -$0.83 -$0.13
05/06/2021 Q1 -- -- -$1.09 -$0.87 -$0.22
02/24/2021 Q4 -- -- -$0.94 -$0.47 -$0.47
11/05/2020 Q3 -- -- -$0.78 -$0.36 -$0.42
08/06/2020 Q2 -- -- -$0.57 -$0.36 -$0.21
05/07/2020 Q1 -- -- -$0.29 -$0.39 $0.10
02/24/2020 Q4 -- -- -$0.27 -$0.30 $0.03
11/07/2019 Q3 -- -- -$0.14 -$0.37 $0.23
08/06/2019 Q2 -- -- -$0.13 -$0.35 $0.22
05/09/2019 Q1 -- -- -$0.30 -$0.37 $0.07
03/12/2019 Q4 -- -- -$0.30 -$0.35 $0.05
11/19/2018 Q3 -- -- -$0.29 -$0.29 $0.01

Guardant Health Earnings Questions

  • How Much did Guardant Health Generate in Revenue Last Quarter?

    Guardant Health reported $201.8M worth of top line sales in its most recent quarter.

  • Did Guardant Health Beat Earnings Last Quarter?

    Guardant Health announced earnings per share of -$0.90 which represents a miss of analyst forecast a -$0.50 per share.

  • Is Guardant Health Profitable?

    Guardant Health reported $124.2M that represents $1.00 per share over the last quarter.

  • What is the Analyst Consensus for Guardant Health EPS Next Year?

    Guardant Health's earnings are forecast to decrease from -$3.56 per share to -$1.99 per share next year representing a decrease of -37.91%.

  • When is Guardant Health's Earnings Date?

    Guardant Health's next earnings date is May 9, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is CyberArk The Next Big Cybersecurity Stock?
Is CyberArk The Next Big Cybersecurity Stock?

CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…

Is the Market Going to Go Lower?
Is the Market Going to Go Lower?

The last month has been extremely difficult for the stock…

2 Dividend Stocks to Buy in a Recession
2 Dividend Stocks to Buy in a Recession

While many economists and investors initially expected 2025 to be…

Stock Ideas

Buy
53
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
54
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 41x

Buy
51
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Alerts

Buy
52
RGC alert for Mar 18

Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.

Buy
63
EXOD alert for Mar 18

Exodus Movement [EXOD] is down 3.96% over the past day.

Sell
45
MNPR alert for Mar 18

Monopar Therapeutics [MNPR] is up 0.93% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock